Cogent Biosciences reported earnings of -$ 0.59 per COGT share on Nov 9, 2026, beating analysts' expectations by
| Report Date | Nov 9, 2026 |
|---|---|
| Forecasted EPS | -$ 0.56 |
| Earnings Per Share (Surprise) | -$ 0.59 (-$ 0.03) |
| Last Year's EPS | -$ 0.53 |
| EPS YoY Change |
Out of the last 42 earnings reporting periods, Cogent Biosciences beat analysts’ expectations 13 times and fell short of expectations 22 time(s). Cogent Biosciences reported earnings per share of -$ 0.59 in the last report falling to reach an estimated EPS of -$ 0.56 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 0.56 | -$ 0.59 | -$ 0.55 | |
| Nov 5, 2026 | -$ 0.56 | -$ 0.59 | -$ 0.50 | |
| Aug 10, 2026 | -$ 0.55 | -$ 0.52 | -$ 0.53 | |
| May 5, 2026 | -$ 0.53 | -$ 0.53 | -$ 0.52 | |
| Feb 17, 2026 | -$ 0.51 | -$ 0.55 | -$ 0.61 | |
| Nov 7, 2025 | -$ 0.54 | -$ 0.50 | -$ 0.64 | |
| Aug 5, 2025 | -$ 0.55 | -$ 0.53 | -$ 0.59 | |
| May 6, 2025 | -$ 0.56 | -$ 0.52 | -$ 0.62 | |
| Feb 25, 2025 | -$ 0.59 | -$ 0.61 | -$ 0.63 | |
| Nov 12, 2024 | -$ 0.55 | -$ 0.64 | -$ 0.64 | |
| Aug 6, 2024 | -$ 0.55 | -$ 0.59 | -$ 0.59 | |
| May 7, 2024 | -$ 0.50 | -$ 0.62 | -$ 0.54 | |
| Feb 26, 2024 | -$ 0.54 | -$ 0.63 | -$ 0.56 | |
| Nov 2, 2023 | -$ 0.50 | -$ 0.64 | -$ 0.50 | |
| Aug 8, 2023 | -$ 0.53 | -$ 0.59 | -$ 0.71 | |
| May 9, 2023 | -$ 0.58 | -$ 0.54 | -$ 0.68 | |
| Mar 14, 2023 | -$ 0.50 | -$ 0.56 | -$ 0.61 | |
| Nov 14, 2022 | -$ 0.51 | -$ 0.50 | -$ 0.48 | |
| Aug 9, 2022 | -$ 0.64 | -$ 0.71 | -$ 0.43 | |
| May 10, 2022 | -$ 0.53 | -$ 0.68 | -$ 0.34 |
Cogent Biosciences’s stock was trading at $ 31.65 on Nov 8, 2026 a day before the last earnings report was released.Following the release of the earnings report, COGT’s price decreased to $ 31.64 on Nov 10, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 0.59 | $ 31.65 | $ 31.64 | |
| Nov 5, 2026 | -$ 0.59 | $ 31.49 | $ 31.65 | |
| Aug 10, 2026 | -$ 0.52 | $ 42.39 | $ 38.70 | |
| May 5, 2026 | -$ 0.53 | $ 36.73 | $ 35.87 | |
| Feb 17, 2026 | -$ 0.55 | $ 36.53 | $ 38.35 | |
| Nov 7, 2025 | -$ 0.50 | $ 14.72 | $ 32.46 | |
| Aug 5, 2025 | -$ 0.53 | $ 12.05 | $ 10.97 | |
| May 6, 2025 | -$ 0.52 | $ 5.57 | $ 4.72 | |
| Feb 25, 2025 | -$ 0.61 | $ 7.46 | $ 6.71 | |
| Nov 12, 2024 | -$ 0.64 | $ 10.40 | $ 10.40 | |
| Aug 6, 2024 | -$ 0.59 | $ 9.14 | $ 8.63 | |
| May 7, 2024 | -$ 0.62 | $ 7.57 | $ 7.60 | |
| Feb 26, 2024 | -$ 0.63 | $ 7.44 | $ 7.49 | |
| Nov 2, 2023 | -$ 0.64 | $ 8.19 | $ 8.51 | |
| Aug 8, 2023 | -$ 0.59 | $ 11.03 | $ 11.83 | |
| May 9, 2023 | -$ 0.54 | $ 11.84 | $ 11.66 | |
| Mar 14, 2023 | -$ 0.56 | $ 12.07 | $ 12.16 | |
| Nov 14, 2022 | -$ 0.50 | $ 12.42 | $ 11.71 | |
| Aug 9, 2022 | -$ 0.71 | $ 12.60 | $ 13.81 | |
| May 10, 2022 | -$ 0.68 | $ 5.55 | $ 4.22 |
Cogent Biosciences released its most recent earnings reports in November 2026, November 2026, August 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Cogent Biosciences missed analysts’ expectations during the last earnings period by
